ong-term study of HP-3060
Phase 3
- Conditions
- Perennial allergic rhinitis
- Registration Number
- JPRN-jRCT2080222924
- Lead Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with a diagnosis of perennial allergic rhinitis and symptoms of this condition for at least two years.
Exclusion Criteria
- Patients with rhinosinusitis or with types of rhinitis other than allergic rhinitis, including vasomotor rhinitis and non-allergic rhinitis with eosinophilia.
- Patients receiving hyposensitization therapy or nonspecific immunotherapy who have not reached the maintenance stage.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method